A Study of DS-9606a in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
- Status
- SUSPENDED
- Phase
- PHASE3
Comprehensive Outcomes for After Cancer Health
- Status
- RECRUITING
- Phase
- NA
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Towards an Early Integration of Palliative Care in Oncology
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Ubuntu - I Am Because We Are
- Status
- COMPLETED
- Phase
- NA
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
- Status
- RECRUITING
- Phase
- PHASE2
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Implementing Precision Medicine in cOmmunity HospiTALs
- Status
- RECRUITING
- Phase
- NA
Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2